Individuals Coming Off Anti-Obesity Medications Gain Back Pounds at a Quadrupled Rate Than Dieters

A recent study reveals that individuals who come off blockbuster slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise regimens.

Research printed in a prominent health publication shows that while overweight individuals can lose a large proportion of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month after stopping.

"People purchasing these drugs need to be aware of the potential of fast weight regain when the medication is stopped," cautioned researcher Dr. Susan Jebb.

That rate of recovery means a reversion to starting weight in about one and a half years.

Weighing Treatments

The research, which reviewed dozens of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with conventional dieting.

Scientists emphasize that individuals who lose weight through dieting typically have a less rapid creep back—around 100 grams monthly—post-intervention.

Explaining the Rapid Regain

Doctors suggest the mode of action of the jabs explains the heightened weight return.

These medications mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Artificially providing GLP-1 concentrations far above than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating a significant risk."

A Lifelong Issue?

Health authorities recommend the jabs for people with obesity-related medical conditions, alongside prescribed lifestyle changes.

Professionals contend that, considering the likelihood of relapse, the therapy is often long-term.

This view is echoed by pharmaceutical companies, who state that the findings "highlight the long-term nature of obesity," akin to managing conditions like diabetes.

Patient Testimonies

People who have discontinued the jabs describe a sudden resurgence of hunger.

"It was like something that goes on and I was suddenly ravenous," said an individual.

This difficulty is worsened if users have not adopted permanent lifestyle or habit changes during therapy.

Widespread Adoption

Figures show that a significant number of adults in the UK have used these injections in the past year, with desire being substantial.

• Adoption is more common among females compared to males.
• The middle-aged age group shows the greatest usage rates.
• A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, clinicians emphasize that while these medications are effective agents for weight loss, they are not a magic solution and maintained weight loss hinges on combined lifestyle changes.